4//SEC Filing
Ho Robert 4
Accession 0001209191-22-006391
CIK 0001404644other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:36 PM ET
Size
9.5 KB
Accession
0001209191-22-006391
Insider Transaction Report
Form 4
Ho Robert
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-02-01+70,000→ 70,000 totalExercise: $0.00→ Common Stock (70,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001806254
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:36 PM ET
- Size
- 9.5 KB